Id |
Subject |
Object |
Predicate |
Lexical cue |
T11 |
0-93 |
Sentence |
denotes |
Putative invasive pulmonary aspergillosis patients (sex, age) Probable IPA patient (sex, age) |
T12 |
94-343 |
Sentence |
denotes |
Patient 1 (male, 53 years) Patient 2 (female, 59 years) Patient3 (female, 69 years) Patient 4 (female, 63 years) Patient 5 (male, 43 years) Patient 6 (male, 79 years) Patient 7 (male, 77 years) Patient 8 (female, 75 years) Patient 9 (male, 47 years) |
T13 |
344-593 |
Sentence |
denotes |
Risk factors of severe COVID-19 Hypertension, obesity, ischaemic heart disease Hypertension, diabetes, obesity Hypertension, obesity Hypertension, diabetes, ischaemic heart disease Asthma Hypertension Hypertension, asthma Hypertension, diabetes None |
T14 |
594-674 |
Sentence |
denotes |
EORTC risk factors None None None None Steroids None None None Myeloma, steroids |
T15 |
675-716 |
Sentence |
denotes |
APACHE II score 26 16 11 20 8 16 25 21 10 |
T16 |
717-956 |
Sentence |
denotes |
Thoracic CT-scan/x-ray* Typical COVID-19 Typical COVID-19 Typical COVID-19 Typical COVID-19 Typical COVID-19 Typical COVID-19, segmental lung atelectasis Typical COVID-19, emphysema Typical COVID-19 Typical COVID-19 + one peripheral nodule |
T17 |
957-1073 |
Sentence |
denotes |
Anti-COVID-19 therapies LPV–RTV LPV–RTV, AZI LPV–RTV LPV–RTV AZI LPV–RTV, HCQ, AZI LPV–RTV, HCQ, AZI LPV–RTV, AZI No |
T18 |
1074-1135 |
Sentence |
denotes |
Steroids to treat pneumonia† Yes No Yes Yes No Yes Yes Yes No |
T19 |
1136-1191 |
Sentence |
denotes |
Renal replacement therapy Yes No No Yes No No Yes No No |
T20 |
1192-1238 |
Sentence |
denotes |
Vasopressor Yes Yes Yes Yes No Yes Yes Yes Yes |
T21 |
1239-1292 |
Sentence |
denotes |
Pulmonary specimen‡ BAL BAL BA BAL BAL BAL BAL BAL BA |
T22 |
1293-1335 |
Sentence |
denotes |
Invasive pulmonary aspergillosis diagnosis |
T23 |
1336-1366 |
Sentence |
denotes |
BAL culture§ − + + − + + + + + |
T24 |
1367-1409 |
Sentence |
denotes |
BAL/BA qPCR¶ − − 23·9 − − 34·5 29·0 31·7 − |
T25 |
1410-1474 |
Sentence |
denotes |
BAL galactomannan index 0·89 0·03 ND 0·15 0·12 0·05 3·91 0·36 ND |
T26 |
1475-1505 |
Sentence |
denotes |
Serum qPCR¶ − − − ND − − − − − |
T27 |
1506-1554 |
Sentence |
denotes |
β-D-glucan, pg/mL 523 ND 7·8 105 7 23 135 450 14 |
T28 |
1555-1625 |
Sentence |
denotes |
Serum galactomannan index 0·13 0·04 0·03 0·51 0·04 0·02 0·37 0·37 0·09 |
T29 |
1626-1674 |
Sentence |
denotes |
Number of mycological criteria 2 1 2 2 1 2 3 3 1 |
T30 |
1675-1736 |
Sentence |
denotes |
Antifungal therapy None None None None None None VRC CSP None |
T31 |
1737-1831 |
Sentence |
denotes |
Outcome Alive Alive Alive Death (day 0) Alive Alive Death (day 18) Death (day 11) Death day 3) |